IPP Bureau
Thermo Fisher Scientific launches rapid environmental PCR testing solution
By IPP Bureau - February 08, 2022
Rapid testing produces air sample results in 30 minutes
Everest Medicines' trodelvy approved in Singapore for second-line metastatic triple-negative breast cancer
By IPP Bureau - February 08, 2022
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis
By IPP Bureau - February 08, 2022
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines
By IPP Bureau - February 08, 2022
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22
By IPP Bureau - February 08, 2022
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
Merck KGaA restructures life science business to support long-term growth
By IPP Bureau - February 08, 2022
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Granules India Q3FY22 PAT at Rs 100.88 cr.
By IPP Bureau - February 08, 2022
Granules India has reported consolidated financial results for the period ended December 31, 2021
AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
By IPP Bureau - February 08, 2022
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Suven Pharma Q3FY22 PAT at Rs. 160.06 crore
By IPP Bureau - February 08, 2022
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Lupin receives approval from USFDA for Arformoterol Tartrate inhalation
By IPP Bureau - February 08, 2022
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Origin Materials and Minafin form strategic partnership for biobased chemicals
By IPP Bureau - February 08, 2022
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
Biosynthetic Technologies raises $7.5 million
By IPP Bureau - February 08, 2022
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
India grants Emergency Use Authorisation to Sputnik Light
By IPP Bureau - February 07, 2022
This is the ninth Covid-19 vaccine approved in India
Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct
By IPP Bureau - February 07, 2022
Key takeaways of recent quarter & conference call highlights
Lay Sciences launch ImmynlgY, an oral antibody to neutralize Covid-19
By IPP Bureau - February 07, 2022
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
